01875.HK
BioDlink International Company Limited
HKSE · Healthcare · Biotechnology · CN
HKD 3.80
−0.39%Margins
Gross margin
54.0%
EBITDA margin
0.2%
EBIT margin
-8.7%
Net margin
-9.9%
FCF margin
0.5%
-25.2%
Return on equity
-13.2%
Return on assets
-14.1%
Return on invested capital
1.29x
Asset turnover
HKD 122.1M
Cash from operations
HKD 0.42
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026